RevCycleAI← Company Intelligence
Company Intelligence

AKASA

Generative AI company focused on hospital middle revenue cycle workflows, especially clinical documentation integrity and medical coding.
RCM AutomationAI Revenue Cycle AutomationPrivate
Read full research →Website ↗
2019
San Francisco, CA
Private
Venture-backed

RevCycleAI Brief

Published research

Generative AI company focused on hospital middle revenue cycle workflows, especially clinical documentation integrity and medical coding.

Generative AI codingClinical documentation integrityPrebill accuracyRevenue captureMiddle revenue cycle automation

✦ Ask RevCycleAI about AKASA

Pro AI analyst

Go deeper on competitors, positioning, buyers, funding and market signals.

Unlock Ask RevCycleAI →

Key findings

Research highlights

The key proof point is enterprise deployment depth rather than breadth of workflow coverage: Cleveland Clinic's systemwide rollout provides unusually strong evidence that AKASA can move beyond pilots into production across a major health system.

AKASA said its generative AI product suite had grown more than 10x since its mid-2024 launch

Cleveland Clinic expanded AKASA partnership after rolling AI coding across all U.S. locations and moved to systemwide CDI deployment

RevCycleAI Intelligence Scores

Methodology
61
66
64
49

Market Matrix: Major Contender · Impact 64 · Capability 58

Funding & transaction history

1 tracked
2024-06-18 · Series C · $120M

GenAI-powered RCM automation for hospital systems. Uses clinical and financial data to automate coding, prior auth, and claim submission at scale.

Full research

Deep Dive
Open Deep Dive →